Morningstar

Front Month Nymex ULSD Rose 3.39% This Week to Settle at $4.8991 — Data Talk

Provided by Dow Jones

Front Month Nymex ULSD for Nov. delivery gained 16.07 cents per gallon, or 3.39% to $4.8991 this week 




       --Up for three consecutive weeks 



       --Up eight of the past 10 weeks 



       --Today it is up 5.35 cents or 1.10% 



       --Snaps a two session losing streak 



       --Off 6.90% from its 52-week high of $5.262 hit Tuesday, Sept. 15, 2026 



       --Up 138.20% from its 52-week low of $2.0567 hit Wednesday, Jan. 7, 2026 



       --Rose 124.73% from 52 weeks ago 



       --Off 6.90% from its 2026 settlement high of $5.262 hit Tuesday, Sept. 15, 2026 



       --Up 138.20% from its 2026 settlement low of $2.0567 hit Wednesday, Jan. 7, 2026 



       --Off 6.90% from its record high of $5.262 hit Tuesday, Sept. 15, 2026 



       --Month-to-date it is down 1.17% 



       --Year-to-date it is up $2.7785 or 131.02% 





     All prices are calculated based on the settlement price of the current front month contract. 





     Source: Dow Jones Market Data 





  (END) Dow Jones Newswires



  October 16, 2026 14:58 ET (18:58 GMT)


Copyright (c) 2026 Dow Jones & Company, Inc.
  

					The articles, information, and content displayed on this webpage may
					include materials prepared and provided by third parties. Such
					third-party content is offered for informational purposes only and
					is not endorsed, reviewed, or verified by Morningstar.
				
 

					Morningstar makes no representations or warranties regarding the
					accuracy, completeness, timeliness, or reliability of any third-party
					content displayed on this site. The views and opinions expressed in
					third-party content are those of the respective authors and do not
					necessarily reflect the views of Morningstar, its affiliates, or employees.
				
 

					Morningstar is not responsible for any errors, omissions, or delays
					in this content, nor for any actions taken in reliance thereon.
					Users are advised to exercise their own judgment and seek independent
					financial advice before making any decisions based on such content.
					The third-party providers of this content are not affiliated with
					Morningstar, and their inclusion on this site does not imply any
					form of partnership, agency, or endorsement.
				
 

				Popular
				
 
  
 
 
 
 
What’s Ahead for Stocks This Quarter—and Where to Invest
 
Morningstar’s chief market strategist and economist share their outlooks for the fourth quarter of 2026. 
 
 
David Sekera, CFA, Preston Caldwell, and Susan Dziubinski 
 
 
 
Are TIPS ETFs the Best Way to Fight Inflation?
 
Plus, four TIPS ETFs with top marks from Morningstar, and what you need to know before investing. 
 
 
Daniel Sotiroff and Ivanna Hampton 
 
 
 
10 Best Blue-Chip Stocks to Buy for the Long Term
 
The stocks of these high-quality companies look cheap today. 
 
 
Tori Brovet 
 
 
 
This 1-Star Stock Trades at a 94% Premium. Is It Time to Sell?
 
Even with significant growth potential, the stock’s lofty valuation is difficult to justify. 
 
 
Sean Dunlop, CFA 
 
 
 
33 Undervalued Stocks to Buy Before the Market Shifts Again
 
Here’s the new list of Morningstar’s top analyst picks for the fourth quarter of 2026. 
 
 
Susan Dziubinski and Tori Brovet 
 
 
 
 

			Sponsor Center